Key result
Female sex is linked to ~24% higher 3-year AF recurrence after initial ablation versus males.
Why the study?
The impact of sex differences on the clinical outcomes of radiofrequency catheter ablation of atrial fibrillation remains controversial.
Does female sex increase the risk of AF recurrence and adverse clinical outcomes in patients undergoing initial radiofrequency catheter ablation for atrial fibrillation?
Observational (n=5,010)
Yes
Does female sex increase the risk of AF recurrence and adverse clinical outcomes in patients undergoing initial radiofrequency catheter ablation for atrial fibrillation?
Female patients undergoing initial RFCA for AF have a significantly higher risk of long-term AF recurrence, de novo pacemaker implantation, heart failure hospitalization, and major bleeding compared to males.
Answers are grounded in this paper and cite their sources.
May support closer post-ablation monitoring in women; leaves open whether sex-specific strategies improve outcomes in randomized trials.
AIM: The impact of sex differences on the clinical outcomes of radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) is controversial. We investigated the sex differences regarding the efficacy and clinical outcomes of RFCA of AF. METHODS AND RESULTS: We conducted a large-scale, prospective, multicentre, observational study (Kansai Plus Atrial Fibrillation Registry). We enrolled 5010 consecutive patients who underwent an initial RFCA of AF at 26 centres (64 ± 10 years; non-paroxysmal AF, 35.7%). The median follow-up duration was 2.9 years. Female patients (n = 1369, 27.3%) were older (female vs. male, 68 ± 9 vs. 63 ± 11 years, P < 0.0001) with a lower prevalence of non-paroxysmal AF (27.1% vs. 38.9%, P < 0.0001). Fewer females experienced time-dependent pulmonary vein (PV) reconnections and more females received a non-PV foci ablation than males in the index RFCA. The 3-year cumulative incidence of AF recurrences in the multivariate analysis after single procedures was significantly higher in females than males (43.3% vs. 39.0%, log rank P = 0.0046). Females remained an independent predictor of AF recurrence (hazard ratio 1.24; 95% confidence interval 1.12-1.38, P < 0.0001). The AF recurrence rates after multiple procedures were also higher in females, but fewer females experienced PV reconnections during second sessions. More females experienced de novo pacemaker implantations during the long-term follow-up. Females were associated with a higher risk of heart failure hospitalizations and major bleeding after RFCA in the multivariate analysis. CONCLUSIONS: Females experienced more frequent AF recurrences probably due to non-PV arrhythmogenicity and de novo pacemaker implantations than males during the long-term follow-up after RFCA of AF.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2020) conducted an observational in Atrial fibrillation (n=5,010). Female sex vs. Male sex was evaluated on 3-year cumulative incidence of atrial fibrillation recurrences after single procedures (HR 1.24, 95% CI 1.12-1.38, p=<0.0001). Female sex was associated with a higher 3-year incidence of atrial fibrillation recurrence after initial ablation compared to males.
Synapse has enriched 10 related papers. Consider them for comparative context: